000 | 01560 a2200433 4500 | ||
---|---|---|---|
005 | 20250517155343.0 | ||
264 | 0 | _c20180416 | |
008 | 201804s 0 0 eng d | ||
022 | _a2219-2840 | ||
024 | 7 |
_a10.3748/wjg.v23.i18.3214 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFilipec Kanizaj, Tajana | |
245 | 0 | 0 |
_aInflammatory bowel disease in liver transplanted patients. _h[electronic resource] |
260 |
_bWorld journal of gastroenterology _cMay 2017 |
||
300 |
_a3214-3227 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 | _aAnastomosis, Surgical |
650 | 0 | 4 |
_aCholangitis, Sclerosing _xcomplications |
650 | 0 | 4 | _aColonoscopy |
650 | 0 | 4 |
_aColorectal Neoplasms _xprevention & control |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 |
_aInflammatory Bowel Diseases _xcomplications |
650 | 0 | 4 |
_aLiver Failure _xcomplications |
650 | 0 | 4 |
_aLiver Transplantation _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMesalamine _xtherapeutic use |
650 | 0 | 4 | _aPostoperative Period |
650 | 0 | 4 | _aProctocolectomy, Restorative |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aTacrolimus _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
700 | 1 | _aMijic, Maja | |
773 | 0 |
_tWorld journal of gastroenterology _gvol. 23 _gno. 18 _gp. 3214-3227 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3748/wjg.v23.i18.3214 _zAvailable from publisher's website |
999 |
_c27231817 _d27231817 |